Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review

Abstract Background Ketamine has emerged as a rapid-acting antidepressant in treatment-resistant depression (TRD) increasingly used in non-research, clinical settings. Few studies, however, have examined neurocognitive effects of repeated racemic ketamine infusion treatments in patients with TRD. In...

Full description

Bibliographic Details
Main Authors: Danika Dai, Courtney Miller, Violeta Valdivia, Brian Boyle, Paula Bolton, Shuang Li, Steve Seiner, Robert Meisner
Format: Article
Language:English
Published: BMC 2022-02-01
Series:BMC Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s12888-022-03789-3